Radiology AI vendor to sell use of its algorithms for $1 per scan

A medical AI startup is offering its image-interpretation algorithms for a flat $1 per read.

Israel-based Zebra Medical Vision has developed algorithms for detecting 11 ailments so far, and it plans to add another six by the end of this year, according to a news release sent by the company.

The company says its software automatically integrates algorithms’ findings into PACS and RIS, helping radiologists with interpretation accuracy as well as reporting efficiency.

However, its main stated aim is to help diagnosticians in parts of the world where radiologists are in short supply.

With the $1-per-scan model, “we hope to facilitate adoption globally, especially in countries where access to radiology is difficult,” Elad Benjamin, Zebra Med’s co-founder and CEO, says in prepared remarks. “[W]e believe that a true difference can be made in the provision of radiology services worldwide.”

The company’s analytics engine is deployed at more than 50 hospitals globally and has analyzed more than 1 million patient scans to date, according to the news release.

As the radiological AI space continues to grow into one of the most hotly pursued markets in U.S. healthcare, Zebra is sure to be challenged here by competitors large and small. In turn, its stroke toward price transparency could challenge the field to compete more intensely on both price and transparency.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.